Therapeutic effects of Ataining on immune ulcerative colitis induced by calf colonic mucosal protein in rats

World Chinese Journal of Digestology

Volumn 16, Issue 1, 2008, Pages 25-32

  Wang, Wen Jie ^a   Wang, Lin ^a   Liu, Yang ^a   Peng, Shan Ying ^a   Zhang, Fu Ying ^a   Li, Ping ^a   Wan, Fu Chang ^b   Cui, Yun Long ^c,d  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b Qingdao Research Center of Microecology Engineering Technology   (China)

^c Qingdao Eastsea Pharmaceutical Co Ltd   (China)

^d Qingdao Eastern Sea Pharmaceutical Co Ltd   (China)

Author keywords

Ataining; Clostridium butyricum; Immune ulcerative colitis; Mesalazine

Indexed keywords

CALF COLONIC MUCOSAL PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 8; MESALAZINE; PROBIOTIC AGENT; PROTEIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL STRAIN; BODY WEIGHT; CLOSTRIDIUM BUTYRICUM; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; HISTOPATHOLOGY; IMMUNODIFFUSION; IMMUNOGLOBULIN BLOOD LEVEL; MESENTERY; MICROSCOPY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; ORGAN WEIGHT; PROTEIN BLOOD LEVEL; RAT; T LYMPHOCYTE; THERAPY EFFECT; ULCERATIVE COLITIS;

EID: 42049117117     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v16.i1.25     Document Type: Article

References (36)

1. Masaya Sasaki, Yoshio Araki, Tomoyuki Tsujikawa, Akira Andoh and Yoshihide Fujiyama. Intestinal Cell Proliferation and Microflora. Journal of Intestinal Microbiology 2005; 19: 1-8
2. Chinese source
3. Araki Y, Andoh A, Takizawa J, Takizawa W, Fujiyama Y. Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int J Mol Med 2004; 13: 577-580
4. Araki Y, Andoh A, Fujiyama Y, Takizawa J, Takizawa W, Bamba T. Oral administration of a product derived from Clostridium butyricum in rats. Int J Mol Med 2002; 9: 53-57
5. Araki Y, Andoh A, Fujiyama Y, Takizawa J, Takizawa W, Bamba T. Short-term oral administration of a product derived from a probiotic, Clostridium butyricum induced no pathological effects in rats. Int J Mol Med 2002; 9: 173-177
6. Chinese source
7. Chinese source
8. Chinese source
9. Chinese source
10. Chinese source
11. Papadakis KA, Targan SR. The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm Bowel Dis 2000; 6: 303-313
12. Yang SK, Eckmann L, Panja A, Kagnoff MF. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 1997; 113: 1214-1223
13. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95: 55-65
14. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15: 675-705
15. McCormick BA, Parkos CA, Colgan SP, Carnes DK, Madara JL. Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. J Immunol 1998; 160: 455-166
16. Huang GT, Eckmann L, Savidge TC, Kagnoff MF. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion. J Clin Invest 1996; 98: 572-583
17. Begue B, Sarnacki S, le Deist F, Buc H, Gagnon J, Meo T, Cerf-Bensussan N. HML-1, a novel integrin made of the beta 7 chain and of a distinctive alpha chain, exerts an accessory function in the activation of human IEL via the CD3-TCR pathway. Adv Exp Med Biol 1995; 371A: 67-75
18. Wershil BK. Role of mast cells and basophils in gastrointestinal inflammation. Chem Immunol 1995; 62: 187-203
19. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996; 38: 216-222
20. Chinese source
21. Saarialho-Kere UK. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 1998; 290 Suppl: S47-54
22. Sakaguchi T, Brand S, Reinecker HC. Mucosal barrier and immune mediators. Curr Opin Gastroenterol 2001; 17: 573-577
23. Chinese source
24. Chinese source
25. Chinese source
26. Chinese source
27. Chinese source
28. Chinese source
29. Derkx B, Taminiau J, Radema S, Stronkhorst A, Wortel C, Tytgat G, van Deventer S. Tumour-necrosis-factor antibody treatment in Crohn's disease. Lancet 1993; 342: 173-174
30. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-1405
31. Wirtz S, Neurath MF. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis 2000; 15: 144-160
32. Venkatraman A, Ramakrishna BS, Pulimood AB, Patra S, Murthy S. Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate. Scand J Gastroenterol 2000; 35: 1053-1059
33. Kanauchi O, Andoh A, Iwanaga T, Fujiyama Y, Mitsuyama K, Toyonaga A, Bamba T. Germinated barley foodstuffs attenuate colonic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model. J Gastroenterol Hepatol 1999; 14: 1173-1179
34. Hata K, Andoh A, Sato H, Araki Y, Tanaka M, Tsujikawa T, Fujiyama Y, Bamba T. Sequential changes in luminal microflora and mucosal cytokine expression during developing of colitis in HLA-B27/beta2-microglobulin transgenic rats. Scand J Gastroenterol 2001; 36: 1185-1192
35. Mikami T, Yoshida T, Akino F, Motoori T, Yajima M, Okayasu I. Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors. Association with survivin and bcl-2. Am J Clin Pathol 2003; 119: 723-730
36. Luhrs H, Gerke T, Muller JG, Melcher R, Schauber J, Boxberge F, Scheppach W, Menzel T. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002; 37: 458-466